This strategy may also be combined with standard chemotherapy, since in vivo evidence in a mouse ovarian carcinoma model indicates that combining docetaxel with anti-CD73 antibody therapy is more effective than using both treatments individually [48]. This evidence concerns the gene NT5E and ovarian carcinoma.